蛋白质组学特征可改善常见与罕见疾病的风险预测
研究基于英国生物银行制药蛋白质组学项目中41,931名个体的约3,000种血浆蛋白与临床信息,为218种常见和罕见疾病的10年发病率构建稀疏预测模型。仅含5至20种蛋白的稀疏模型对67种病理多样疾病的预测性能优于仅用基本临床信息的模型,中位delta C指数为0.07,并在52种疾病中优于基本临床信息联合37项临床检测数据的模型。稀疏蛋白模型在EPIC-Norfolk研究中对所测试的6种疾病的外重复显示出良好泛化性。
要点
- 在41,931名个体中,稀疏蛋白模型对67种疾病的预测优于仅用基本临床信息的模型,中位delta C指数为0.07。
- 稀疏蛋白模型对52种疾病的预测优于基本临床信息联合37项临床检测数据的模型。
- 对多发性骨髓瘤,5种预测蛋白中有4种在初诊患者骨髓单细胞RNA测序中显示浆细胞特异性表达。
核心结论
- 包含疾病特异性蛋白和跨多种疾病共享蛋白预测因子的稀疏血浆蛋白特征,可对常见和罕见疾病提供有临床实用价值的预测。
研究设计与样本
- 研究纳入英国生物银行制药蛋白质组学项目的41,931名个体,整合约3,000种血浆蛋白测量与临床信息。
- 为218种常见和罕见疾病(81至6,038例病例)的10年发病率构建稀疏预测模型。
- 将蛋白质组数据开发的预测模型与仅用基本临床信息或基本临床信息联合37项临床检测数据开发的模型进行比较。
- 在EPIC-Norfolk研究中对稀疏蛋白模型进行外重复。
主要发现
- 仅含5至20种蛋白的稀疏模型对67种病理多样疾病的预测性能优于仅用基本临床信息的模型(中位delta C指数=0.07;范围=0.02-0.31)。
- 稀疏蛋白模型对52种疾病的预测优于基本临床信息联合临床检测数据的模型,包括多发性骨髓瘤、非霍奇金淋巴瘤、运动神经元病、肺纤维化和扩张型心肌病。
- 对多发性骨髓瘤,初诊患者骨髓单细胞RNA测序显示5种预测蛋白中有4种在浆细胞中特异性表达。
- 稀疏蛋白模型在EPIC-Norfolk研究中对所测试的6种疾病的外重复显示出良好泛化性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For many diseases there are delays in diagnosis due to a lack of objective biomarkers for disease onset. Here, in 41,931 individuals from the United Kingdom Biobank Pharma Proteomics Project, we integrated measurements of ~3,000 plasma proteins with clinical information to derive sparse prediction models for the 10-year incidence of 218 common and rare diseases (81-6,038 cases). We then compared prediction models developed using proteomic data with models developed using either basic clinical information alone or clinical information combined with data from 37 clinical assays. The predictive performance of sparse models including as few as 5 to 20 proteins was superior to the performance of models developed using basic clinical information for 67 pathologically diverse diseases (median delta C-index = 0.07; range = 0.02-0.31). Sparse protein models further outperformed models developed using basic information combined with clinical assay data for 52 diseases, including multiple myeloma, non-Hodgkin lymphoma, motor neuron disease, pulmonary fibrosis and dilated cardiomyopathy. For multiple myeloma, single-cell RNA sequencing from bone marrow in newly diagnosed patients showed that four of the five predictor proteins were expressed specifically in plasma cells, consistent with the strong predictive power of these proteins. External replication of sparse protein models in the EPIC-Norfolk study showed good generalizability for prediction of the six diseases tested. These findings show that sparse plasma protein signatures, including both disease-specific proteins and protein predictors shared across several diseases, offer clinically useful prediction of common and rare diseases.
引用
- Carrasco-Zanini J, Pietzner M, Davitte J, et al. Proteomic signatures improve risk prediction for common and rare diseases. Nat Med. 2024. PMID: 39039249. doi:10.1038/s41591-024-03142-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。